Document is current
Any future updates will be listed below
-
Authors
Franke, Cassandra J. https://orcid.org/0000-0001-8969-1837
Griffin, Jason W. https://orcid.org/0000-0001-5341-0124
Naples, Adam J. https://orcid.org/0000-0002-6298-5699
Wolf, Julie M. https://orcid.org/0000-0001-6677-7654
McPartland, James C. https://orcid.org/0000-0002-2570-0746
-
Funding
Funding for this research was provided by:
Hilibrand Foundation (Hilibrand Foundation)
National Institute of Mental Health (NIMH R01 MH100173, NIMH R01 MH100173-02S1)
- License Information
-
More Information
Article History
Accepted: 29 October 2024
First Online: 18 November 2024
Declarations
:
: All study procedures were approved by the Institutional Review Board at the Yale University School of Medicine.
: Written informed consent was obtained from the legal guardians of all study participants.
: Cassandra J. Franke, Jason W. Griffin, Adam J. Naples, and Julie M. Wolf declare no potential conflicts of interest with respect to the research, authorship and/or publication of this article. James C. McPartland consults or has consulted with Customer Value Partners, Bridgebio, Determined Health, Apple, and BlackThorn Therapeutics, has received research funding from Janssen Research and Development, serves on the Scientific Advisory Boards of Pastorus and Modern Clinics, and receives royalties from Guilford Press, Lambert, Oxford, and Springer.
